METHODS	A total of 3,602 STEMI patients undergoing primary percutaneous coronary intervention ( PCI ) were randomized to bivalirudin ( n = 1,800 ) versus unfractionated heparin ( UFH ) plus a glycoprotein IIb/IIIa inhibitor ( GPI ) ( UFH+GPI ; n = 1,802 ) .\